Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.

Criscitiello, C; Azim, H A; Agbor-tarh, D; de Azambuja, E; Piccart, M; Baselga, J; Eidtmann, H; Di Cosimo, S; Bradbury, I; Rubio, I T.

Ann Oncol ; 24(8): 1980-5, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23567146

2.

Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer.

Piccart, M J; Gore, M; Ten Bokkel Huinink, W; Van Oosterom, A; Verweij, J; Wanders, J; Franklin, H; Bayssas, M; Kaye, S.

J Natl Cancer Inst ; 87(9): 676-81, 1995 May 03.

Artículo en Inglés | MEDLINE | ID: mdl-7752272

3.

Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam.

Razavi, D; Delvaux, N; Farvacques, C; De Brier, F; Van Heer, C; Kaufman, L; Derde, M P; Beauduin, M; Piccart, M.

J Clin Oncol ; 11(7): 1384-90, 1993 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-8315437

4.

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

Tomiak, E; Piccart, M J; Kerger, J; Lips, S; Awada, A; de Valeriola, D; Ravoet, C; Lossignol, D; Sculier, J P; Auzannet, V.

J Clin Oncol ; 12(7): 1458-67, 1994 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-7912725

5.

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over.

Paridaens, R; Biganzoli, L; Bruning, P; Klijn, J G; Gamucci, T; Houston, S; Coleman, R; Schachter, J; Van Vreckem, A; Sylvester, R; Awada, A; Wildiers, J; Piccart, M.

J Clin Oncol ; 18(4): 724-33, 2000 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-10673513

6.

Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer.

Piccart, M J; Klijn, J; Paridaens, R; Nooij, M; Mauriac, L; Coleman, R; Bontenbal, M; Awada, A; Selleslags, J; Van Vreckem, A; Van Glabbeke, M.

J Clin Oncol ; 15(9): 3149-55, 1997 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-9294478

7.

Use and abuse of taxanes in the management of metastatic breast cancer.

Bernard-Marty, C; Cardoso, F; Piccart, M J.

Eur J Cancer ; 39(14): 1978-89, 2003 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-12957452

8.

A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors.

Van Den Neste, E; de Valeriola, D; Kerger, J; Bleiberg, H; Kusenda, Z; Brassinne, C; Bartholomeus, S; Selleslags, J; Hennebert, P; Wythouck, H; Cazenave, I; Lefresne-Soulas, F; Piccart, M.

Clin Cancer Res ; 6(1): 64-71, 2000 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-10656433

9.

Taxanes in the adjuvant treatment of breast cancer: why not yet?

Piccart, M J; Lohrisch, C; Duchateau, L; Buyse, M.

J Natl Cancer Inst Monogr ; (30): 88-95, 2001.

Artículo en Inglés | MEDLINE | ID: mdl-11773299

10.

Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer Center.

Kaye, S B; Piccart, M; Aapro, M; Kavanagh, J.

Eur J Cancer ; 31A Suppl 4: S14-7, 1995.

Artículo en Inglés | MEDLINE | ID: mdl-7577099

11.

Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview.

Kaye, S B; Piccart, M; Aapro, M; Francis, P; Kavanagh, J.

Eur J Cancer ; 33(13): 2167-70, 1997 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-9470802

12.

Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist.

Kramer, J A; Curran, D; Piccart, M; de Haes, J C; Bruning, P F; Klijn, J G; Bontenbal, M; van Pottelsberghe, C; Groenvold, M; Paridaens, R.

Eur J Cancer ; 36(12): 1488-97, 2000 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-10930796

13.

Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.

Kramer, J A; Curran, D; Piccart, M; de Haes, J C; Bruning, P; Klijn, J; Van Hoorebeeck, I; Paridaens, R.

Eur J Cancer ; 36(12): 1498-506, 2000 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-10930797

14.

Future perspectives of docetaxel (Taxotere) in front-line therapy.

Piccart, M J; Di Leo, A.

Semin Oncol ; 24(4 Suppl 10): S10-27-S10-33, 1997 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-9275004

15.

A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923.

Hamilton, A; Larsimont, D; Paridaens, R; Drijkoningen, M; van de Vijver, M; Bruning, P; Hanby, A; Houston, S; Treilleux, I; Guastalla, J P; Van Vreckem, A; Sylvester, R; Piccart, M.

Clin Breast Cancer ; 1(3): 233-40; discussion 241-2, 2000 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-11899648

16.

["Taxanes: an action mechanism at the cellular level, significant clinical progress in the treatment of cancers of the ovary and breast"]. / "Les taxanes: d'un mécanisme d'action original à l'échelon cellulaire, à des progrès cliniques significatifs dans le traitement des cancers de l'ovaire et du sein".

Piccart, M J.

Bull Mem Acad R Med Belg ; 153(5-6): 285-92; discussion 292-4, 1998.

Artículo en Francés | MEDLINE | ID: mdl-9988934

17.

[Optimal therapeutic strategies in ovarian epithelial cancer in 1997]. / Stratégies thérapeutiques optimales dans le cancer épithélial de l'ovaire en 1997.

Piccart, M J; Nogaret, J M.

Rev Med Brux ; 18(4): 198-203, 1997 Sep.

Artículo en Francés | MEDLINE | ID: mdl-9411642

18.

Taxoid compounds in breast cancer: current status and future prospects.

Piccart, M J.

Cancer Treat Res ; 78: 185-207, 1995.

Artículo en Inglés | MEDLINE | ID: mdl-8595143

19.

A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours.

Dumez, H; Awada, A; Piccart, M; Assadourian, S; Semiond, D; Guetens, G; de Boeck, G; Maes, R A A; de Bruijn, E A; van Oosterom, A.

Ann Oncol ; 17(7): 1158-65, 2006 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-16600980

20.

Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG).

Biganzoli, L; Goldhirsch, A; Straehle, C; Castiglione-Gertsch, M; Therasse, P; Aapro, M; Minisini, A; Piccart, M J.

Ann Oncol ; 15(2): 207-10, 2004 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-14760110

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: